Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Bonardi

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|October 10, 2022
Dependence on linkers' flexibility designed for benzenesulfonamides targeting discovery of novel hCA IX inhibitors as potent anticancer agentsHaytham O Tawfik, Amany Belal, Mohammed A S Abourehab, et al.
Bioorganic Chemistry|August 20, 2025
Studies on Azasugar-based sulfonamides: a new class of Carbonic Anhydrase inhibitorsDebora Pratesi, Francesco Brenzini Biagioni, Camilla Matassini, et al.
ACS Medicinal Chemistry Letters|November 20, 2020
Benzoxaboroles: New Potent Inhibitors of the Carbonic Anhydrases of the Pathogenic Bacterium <i>Vibrio cholerae</i>Alessandro Bonardi, Alessio Nocentini, Roberta Cadoni, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 21, 2021
Inhibition of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium <i>Vibrio cholerae</i> with aromatic sulphonamides and clinically licenced drugs - a joint docking/molecular dynamics studyAlessandro Bonardi, Alessio Nocentini, Sameh Mohamed Osman, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 2, 2020
Novel insights on saccharin- and acesulfame-based carbonic anhydrase inhibitors: design, synthesis, modelling investigations and biological activity evaluationPaolo Guglielmi, Giulia Rotondi, Daniela Secci, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 9, 2021
Calixarenes Incorporating Sulfonamide Moieties: Versatile Ligands for Carbonic Anhydrases InhibitionDavide Sbravati, Alessandro Bonardi, Silvia Bua, et al.
European Journal of Medicinal Chemistry|April 23, 2024
Probing benzenesulfonamide-thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: α-glucosidase and carbonic anhydrase IIMona A Gamal, Samar H Fahim, Simone Giovannuzzi, et al.
European Journal of Medicinal Chemistry|September 3, 2019
From random to rational: A discovery approach to selective subnanomolar inhibitors of human carbonic anhydrase IV based on the Castagnoli-Cushman multicomponent reactionStanislav Kalinin, Alessio Nocentini, Alexander Kovalenko, et al.
Journal of Medicinal Chemistry|August 29, 2024
Harnessing Nitric Oxide-Donating Benzofuroxans for Targeted Inhibition of Carbonic Anhydrase IX in CancerSilvia Bua, Alessio Nocentini, Alessandro Bonardi, et al.
Bioorganic & Medicinal Chemistry|September 18, 2023
Design and synthesis of sulfonamides incorporating a biotin moiety: Carbonic anhydrase inhibitory effects, antiproliferative activity and molecular modeling studiesPaloma Begines, Alessandro Bonardi, Alessio Nocentini, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Journal of Enzyme Inhibition and Medicinal Chemistry|October 10, 2022
Dependence on linkers' flexibility designed for benzenesulfonamides targeting discovery of novel hCA IX inhibitors as potent anticancer agentsHaytham O Tawfik, Amany Belal, Mohammed A S Abourehab, et al.
Bioorganic Chemistry|August 20, 2025
Studies on Azasugar-based sulfonamides: a new class of Carbonic Anhydrase inhibitorsDebora Pratesi, Francesco Brenzini Biagioni, Camilla Matassini, et al.
ACS Medicinal Chemistry Letters|November 20, 2020
Benzoxaboroles: New Potent Inhibitors of the Carbonic Anhydrases of the Pathogenic Bacterium <i>Vibrio cholerae</i>Alessandro Bonardi, Alessio Nocentini, Roberta Cadoni, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 21, 2021
Inhibition of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium <i>Vibrio cholerae</i> with aromatic sulphonamides and clinically licenced drugs - a joint docking/molecular dynamics studyAlessandro Bonardi, Alessio Nocentini, Sameh Mohamed Osman, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 2, 2020
Novel insights on saccharin- and acesulfame-based carbonic anhydrase inhibitors: design, synthesis, modelling investigations and biological activity evaluationPaolo Guglielmi, Giulia Rotondi, Daniela Secci, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|December 9, 2021
Calixarenes Incorporating Sulfonamide Moieties: Versatile Ligands for Carbonic Anhydrases InhibitionDavide Sbravati, Alessandro Bonardi, Silvia Bua, et al.
European Journal of Medicinal Chemistry|April 23, 2024
Probing benzenesulfonamide-thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: α-glucosidase and carbonic anhydrase IIMona A Gamal, Samar H Fahim, Simone Giovannuzzi, et al.
European Journal of Medicinal Chemistry|September 3, 2019
From random to rational: A discovery approach to selective subnanomolar inhibitors of human carbonic anhydrase IV based on the Castagnoli-Cushman multicomponent reactionStanislav Kalinin, Alessio Nocentini, Alexander Kovalenko, et al.
Journal of Medicinal Chemistry|August 29, 2024
Harnessing Nitric Oxide-Donating Benzofuroxans for Targeted Inhibition of Carbonic Anhydrase IX in CancerSilvia Bua, Alessio Nocentini, Alessandro Bonardi, et al.
Bioorganic & Medicinal Chemistry|September 18, 2023
Design and synthesis of sulfonamides incorporating a biotin moiety: Carbonic anhydrase inhibitory effects, antiproliferative activity and molecular modeling studiesPaloma Begines, Alessandro Bonardi, Alessio Nocentini, et al.
Pageof 11